The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
Open accessAbstract
BACKGROUND: Cardiovascular disease causes severe morbidity and mortality in type 1 diabetes, although the specific risk factors and whether chronic hyperglycemia has a role are unknown. We examined the progression of carotid intima-media thickness, a measure of atherosclerosis, in a population with type 1 diabetes. METHODS: As part of the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the long-term follow-up of the Diabetes Control and Complications Trial (DCCT), 1229 patients with type 1 diabetes underwent B-mode ultrasonography of the internal and common carotid arteries in 1994-1996 and again in 1998-2000. We assessed the intima-media thickness in 611 subjects who had been randomly assigned to receive conventional diabetes treatment during the DCCT and in 618 who had been assigned to receive intensive diabetes treatment. RESULTS: At year 1 of the EDIC study, the carotid intima-media thickness was similar to that in an age- and sex-matched nondiabetic population. After six years, the intima-media thickness was significantly greater in the diabetic patients than in the controls. The mean progression of the intima-media thickness was significantly less in the group that had received intensive therapy during the DCCT than in the group that had received conventional therapy (progression of the intima-media thickness of the common carotid artery, 0.032 vs. 0.046 mm; P=0.01; and progression of the combined intima-media thickness of the common and internal carotid arteries, -0.155 vs. 0.007; P=0.02) after adjustment for other risk factors. Progression of carotid intima-media thickness was associated with age, and the EDIC base-line systolic blood pressure, smoking, the ratio of low-density lipoprotein to high-density lipoprotein cholesterol, and urinary albumin excretion rate and with the mean glycosylated hemoglobin value during the mean duration (6.5 years) of the DCCT. CONCLUSIONS: Intensive therapy during the DCCT resulted in decreased progression of intima-media thickness six years after the end of the trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive glycemic management resulting in lower A1C levels has also been shown to have a beneficial effect on cardiovascular disease (CVD) complications in type 1 diabetes (9,10)”
From Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Applied Regression Analysis (2nd ed).
de Carvalho, J. F., Draper, N. R., & Smith, H. (1981) · Journal of the American Statistical Association · doi:10.2307/2287608 · Cited by 3,054
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Albert Hofman, D., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,333
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 813
Urogenital Autonomic Dysfunction in Diabetes
Braffett, B. H., Wessells, H., & Sarma, A. V. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0824-5 · Cited by 23
Subclinical vascular disease in patients with diabetes is associated with insulin resistance
Adeva‐Andany, M. M., Funcasta-Calderón, R., Fernández‐Fernández, C., Ameneiros-Rodríguez, E., & Domínguez-Montero, A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.025 · Cited by 22
Cardiovascular disease in young People with Type 1 Diabetes: Search for Cardiovascular Biomarkers
Schäfer, M., Nadeau, K. J., & Reusch, J. E. B. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107651 · Cited by 26
Głowińska‐Olszewska, B., Urban, M., Urban, B. E., Tołwińska, J., & Szadkowska, A. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0253-7 · Cited by 23
“stage in adolescents it may have an indirect harmful effect via the influence on lipid modification [25].”
BackgroundGerstein, H. C., & Rosenstock, J. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.11.002 · Cited by 23
“Moreover, in the DCCT follow-up study [26], allocation to the intensive group reduced posttrial development of carotid atherosclerosis, a marker for the risk for CV events.”
BackgroundIs reversal of endothelial dysfunction still an attractive target in modern cardiology?
Mordi, I. R. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.824 · Cited by 22
Zimmerman, M. A., & Flores, S. C. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.04.026 · Cited by 23
Washio, K., Kusunoki, Y., Tsunoda, T., Osugi, K., Ohigashi, M., Murase, T., Nakamura, T., Matsuo, T., Konishi, K., Katsuno, T., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01362-1 · Cited by 22
Truong, U. T., Maahs, D. M., & Daniels, S. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0018 · Cited by 22
Soliman, E. Z., Backlund, J. C., Bebu, I., Li, Y., Zhang, Z., Cleary, P. A., & Lachin, J. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002882 · Cited by 22
Triggered release of inhaled insulin from the agglomerated vesicles: Pharmacodynamic studies in rats
Karathanasis, E., Bhavane, R. C., & Annapragada, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.004 · Cited by 22
Kornowski, R., & Fuchs, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.016 · Cited by 22
Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes
Meneghini, L. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31802ed2ea · Cited by 22
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Donner, T. W., & Joseph, J. J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50286 · Cited by 21
Suzuki, E., Yoshimura, T., Omura, Y., Sakaguchi, M., Nishio, Y., Maegawa, H., Hisatomi, A., Fujimoto, K., Takeda, J., & Kashiwagi, A. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.955 · Cited by 21
“Previous studies found that endothelial dysfunction, increased intimamedia thickness and arterial stiffness are retarded or reversed by improvement of glycaemic control in diabetic patients [13,14].”
BackgroundImportance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients
Luna, P., Guarner‐Lans, V., Farías, J. M., Hernández‐Pacheco, G., & Martínez, M. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.02.008 · Cited by 22
Why do some patients with type 1 diabetes live so long?
Distiller, L. A. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.282 · Cited by 21
Avaliação de dislipidemia e de índices antropométricos em pacientes com Diabetes Mellitus tipo 1
Arcanjo, C. L., Piccirillo, L. J., Machado, I. D. V., de Andrade, C. R. M., Clemente, E. L. S., & Gomes, M. B. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000600015 · Cited by 21
Effect of acarbose to delay progression of carotid intima–media thickness in early diabetes
Patel, Y. R., Kirkman, M. S., Considine, R. V., Hannon, T. S., & Mather, K. J. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2433 · Cited by 20
“diabetic cohort produced subsequent reductions in cardiovascular disease (CVD) event rates [11], which were heralded by reduced rates of IMT progression [12,13].”
BackgroundEpigenetics of diabetic complications
Villeneuve, L. M., & Natarajan, R. D. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.54 · Cited by 20
El-Samahy, M. H., Matter, R. M., Youssef, O. I., Telbany, M. A. S. E. D. E., & Kamal, N. A. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-50 · Cited by 21
Paes, V. M., Barrett, J., Taylor-Robinson, D. C., Chesters, H., Charalampopoulos, D., Dunger, D. B., Viner, R., & Stephenson, T. J. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12850 · Cited by 20
“Landmark trials show that intensive insulin therapy reduces cardiovascular events in adults.(6,49) Although differences in HbA1c account for most of this benefit, multivariate analyses suggest that part of the reduced risk is mediated by reduction in the incidence of diabetic renal disease.”
BackgroundParikh, A., & Daneman, D. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504322783440 · Cited by 20
Polak, J. F., Backlund, J. C., Budoff, M. J., Raskin, P., Bebu, I., & Lachin, J. M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022922 · Cited by 21
Effect of advanced glycation end-products in a wide range of medical problems including COVID-19
Bronowicka-Szydełko, A., Gostomska‐Pampuch, K., Kuzan, A., Pietkiewicz, J., Krzystek‐Korpacka, M., & Gamian, A. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.01.003 · Cited by 23
Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.
Karathanasis, E., Bhavane, R. C., & Annapragada, A. (2007) · PubMed Central · Cited by 20
Tácito, L. H. B., Pires, A. C., & Yugar‐Toledo, J. C. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000281 · Cited by 19
Hyperlipidaemia in Paediatric Patients
Wierzbicki, A. S., & Viljoen, A. (2010) · Drug Safety · doi:10.2165/11319490-000000000-00000 · Cited by 19
Insights into the emerging cardiometabolic prevention and management of diabetes mellitus
Lastra‐González, G., Manrique, C. M., Govindarajan, G., Whaley‐Connell, A. T., & Sowers, J. R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2209 · Cited by 19
de Andrade, C. R. M., Silva, E. L. C., da Matta, M. D. F. B., Castier, M. B., Rosa, M. L. G., & Gomes, M. B. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-87 · Cited by 18
Vastagh, I., Horváth, T., Nagy, G., Varga, T., Juhász, E., Juhász, V., Kollai, M., Bereczki, D., & Somogyi, A. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1133 · Cited by 18
Tabatabaei‐Malazy, O., Fakhrzadeh, H., Sharifi, F., Mirarefin, M., Arzaghi, S. M., Badamchizadeh, Z., Alizadeh-Khoei, M., & Larijani, B. A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0215-5 · Cited by 18
Vetri, F., Qi, M., Xu, H., Oberholzer, J., & Paisansathan, C. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.012 · Cited by 18
“Strict glycemic control through intensive insulin therapy can slow, or even stop, the development of such complications [25].”
BackgroundCardiovascular risk in diabetic end-stage renal disease patients
Wang, A. Y.-M. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00113.x · Cited by 19
Organ-Based Response to Exercise in Type 1 Diabetes
Stehno‐Bittel, L. (2012) · ISRN Endocrinology · doi:10.5402/2012/318194 · Cited by 18
Wang, S., & Li, Y. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00521.2009 · Cited by 18
“DIABETES IS ASSOCIATED WITH increased incidence of atherosclerotic macrovascular disease, which is the major cause of morbidity and mortality in people with diabetes (15, 17, 31).”
BackgroundBlonde, L., Dempster, J. S., Gallivan, J. M., & Warren‐Boulton, E. (2006) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2006.00171.x · Cited by 18
“These findings build on a previous report that intensive therapy as compared with conventional therapy reduced the progression of atherosclerosis,measuredby carotid intima–media thickness (Nathan et al., 2003).”
ResultZhang, Y., Jenkins, A. J., Basu, A., Stoner, J. A., Lopes-Virella, M. F., Klein, R. L., & Lyons, T. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p060657 · Cited by 18
Khanal, S., Bhavnani, N., Mathias, A., Lallo, J., Gupta, S., Ohanyan, V. A., Ferrell, J. M., & Raman, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097899 · Cited by 17
Zhou, Y., Zhang, J., Peng, D.-Q., Chang, J.-R., Cai, Y., Yu, Y.-R., Jia, M.-Z., Wu, W. D., Guan, Y., Tang, C., et al. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9490-7 · Cited by 17
“Ample clinical evidence has suggested that intensive diabetes therapy can significantly reduce the progression of VC [8–10].”
BackgroundPlasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes
Jaffa, M. A., Luttrell, D. K., Schmaier, A. H., Klein, R. L., Lopes-Virella, M. F., Luttrell, L. M., & Jaffa, A. A. (2015) · Diabetes · doi:10.2337/db15-0930 · Cited by 17
Long-term complications of type 1 diabetes: what do we know and what do we need to understand?
Piona, C. A., VENTRICI, C., MARCOVECCHIO, L., CHIARELLI, F., MAFFEIS, C., Bonfanti, R., & Rabbone, I. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.21.06545-9 · Cited by 19
Dabas, A., Yadav, S., & Gupta, V. K. (2014) · International Journal of Pediatrics · doi:10.1155/2014/513460 · Cited by 17
“In a recent publication by DCCT, cIMT has been established as a marker for atherosclerosis when associated with hyperglycemia [48].”
BackgroundTherapy Insight: diabetes and drug-eluting stents
Legrand, V. M. G. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0804 · Cited by 17
Type 1 diabetes mellitus: primary, secondary, and tertiary prevention
Bollyky, J., Sanda, S., & Greenbaum, C. J. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20054 · Cited by 17
Mao, Y., & Zhong, W. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110700 · Cited by 16
Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus
Prendergast, C., & Gidding, S. S. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0454-0 · Cited by 19
Glaser, N. S., Geller, D. H., Haqq, A. M., Gitelman, S. E., & Malloy, M. J. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00709.x · Cited by 16
“In the Epidemiology of Diabetes Interventions and Complications (EDIC) study (a long-term follow-up study of the DCCT cohort), progression of carotid IMT over a 6-yr period was predominantly related to glycemic control, although total and HDL-C levels, and the ratio of LDL-C to HDL-C, were also associated with IMT pro…”
BackgroundChang, Y., Sheu, W. H., Chien, Y. H., Tseng, P., Lee, W., & Chiang, A. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24478 · Cited by 16
“Several studies have indicated that hyperglycemia, the major clinical hallmark of diabetes, increases the risk of atherosclerotic vascular disease [Nathan et al., 2003; Reusch and Wang, 2011].”
BackgroundKrebs, A., Schmidt‐Trucksäss, A., Doerfer, J., Grulich‐Henn, J., Holder, M., Hecker, W., Krebs, K., Barth, M., & Schwab, K. O. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00814.x · Cited by 16
Ogugua, C. F., Chikani, U. N., Okiche, C. Y., & Ibekwe, M. U. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.250.19790 · Cited by 16
“Elevated HbA1c predicts long term microvascular and macrovascular outcomes [4,12].”
Backgroundde Castro, S. H., Castro-Faria-Neto, H. C., & Gomes, M. B. (2005) · The Review of Diabetic Studies · doi:10.1900/rds.2005.2.157 · Cited by 18
Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus
Magge, S. N. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0274-9 · Cited by 16
“Follow up of this patient cohort longitudinally in the Epidemiology of Diabetes Interventions and Complications (EDIC) study demonstrated a relationship between tighter glycemic control and decreased CVD [18] and atherosclerosis [19] in T1DM.”
BackgroundDoggrell, S. A. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1519547 · Cited by 15
Delaney, J. A., Scherzer, R., Polak, J. F., Biggs, M. L., Kronmal, R. A., Chen, H., Sidney, S., & Grünfeld, C. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9442-8 · Cited by 16
“cIMT [24].”
Chan, L. C. K., Shaw, A. A., Busfield, F., Haluska, B. A., Barnett, A. G., Kesting, J. B., Short, L., Marczak, M., & Shaw, J. T. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.005 · Cited by 16
Cardiovascular risk management in type 1 diabetes
Teoh, I. H., Elisaus, P., & Schofield, J. D. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01400-9 · Cited by 15
Diabetes Complications in Childhood Diabetes: New Biomarkers and Technologies
Bjornstad, P., & Maahs, D. M. (2015) · Current Pediatrics Reports · doi:10.1007/s40124-015-0081-0 · Cited by 15
“In adults, intensive therapy in the Diabetes Control and Complications Trial (DCCT) resulted in decreased progression of cIMT 6 years after the end of the trial [32].”
BackgroundPotential benefits of honey in type 2 diabetes mellitus: a review
Kadirvelu, A., & Gurtu, S. (2013) · International journal of collaborative research on internal medicine & public health · Cited by 15
Schwartz, S. S., Grant, S. F. A., & Herman, M. E. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1657358 · Cited by 16
Molecular Mechanisms by Which Metabolic Control May Improve Outcomes
Roith, D. L. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.57 · Cited by 15
Liu, S. M., Wang, L., Wu, X., Wu, J., Liu, D., & Yu, H. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104249 · Cited by 14
Moser, O., Rafferty, J., Eckstein, M. L., Aziz, F., Bain, S. C., Bergenstal, R. M., Sourij, H., & Thomas, R. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15102 · Cited by 17
Serés‐Noriega, T., Perea, V., & Amor, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041097 · Cited by 15
“Finally, the use of this technique is not limited to the phenotyping of CVD risk but may serve as a marker of treatment response [65–67] and may even lead the clinician to intensify cardio-protective treatment and the patient to adopt a healthier lifestyle and be more compliant with treatment [68].”
MethodRad, M. P., Farrokh, D., Vakili, R., Omidbakhsh, M., & Mohammadi, M. (2014) · Europe PMC (PubMed Central) · Cited by 14
Giménez, M., Gilabert, R., Lara, M., & Conget, I. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110388674 · Cited by 16
“In the DCCT, the progression of cIMT in the population of T1D subjects was utilised as a measure of atherosclerosis.(17) The aim of our study was to investigate the presence of preclinical atherosclerosis by assessing endothelial function and cIMT/fIMT, in a group of T1D subjects without additional CVD risk factors an…”
MethodXu, R., Zhang, T., Wan, Y., Fan, Z., & Gao, X. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0963-5 · Cited by 14
Tsutsumi, C., Imagawa, A., Onishi, M., Sano, H., Nakagawa, S., Murase‐Mishiba, Y., Terasaki, J., & Hanafusa, T. (2013) · Diabetology International · doi:10.1007/s13340-013-0108-0 · Cited by 14
Sohn, M., Tan, Y., Klein, R. L., & Jaffa, A. A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00206.x · Cited by 14
The effects of insulin on the endothelium
Fonseca, V. A. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(07)80009-0 · Cited by 15
Occult Vascular Lesions in Patients with Atherothrombotic Events: The AIRVAG Cohort
Luján, S., Puras, E., López‐Bescós, L., Belinchón, J. C., Ml, G., & Guijarro, C. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.02.019 · Cited by 14
Tian, J., Wen, Y., Li, Y., Cheng, H., Yang, H.-Y., Wang, J., Kozman, H., Villarreal, D., & Liu, K. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01514.x · Cited by 13
The Question Is, My Dear Watson, Why Did the Dog Not Bark?
Vinik, A. I. (2011) · Diabetes Care · doi:10.2337/dc11-0146 · Cited by 13
Hong, W. D., Jia, Y. L., & He, Y. (2011) · 老年心脏病学杂志：英文版 · doi:10.3724/sp.j.1263.2011.00024 · Cited by 13
Frigerio, B., Werba, J. P., Amato, M., Ravani, A. L., Sansaro, D., Coggi, D., Vigo, L., Tremoli, E., & Baldassarre, D. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191213120339 · Cited by 13
Intensive insulin regimens: evidence for benefit
Bretzel, R. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802744 · Cited by 13
Spitzer, C., Völzke, H., Barnow, S., Krohn, U., Wallaschofski, H., Lüdemann, J., John, U., Freyberger, H. J., Kerner, W., & Grabe, H. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02369.x · Cited by 13
Use of Insulin to Improve Glycemic Control in Diabetes Mellitus
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6101-3 · Cited by 13
“The intensively treated cohort of DCCT was also shown to have a reduction in carotid IMT (an index of atherosclerosis) compared to the conventionally treated group [109].”
ResultGeorge, B., Bantwal, G., Ayyar, V. S., & Mathew, V. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814551982 · Cited by 13
“Studies like DCCT and EDIC have shown benefits of early intervention in type 1 diabetes for occurrence of macrovascular disease and in slowing the progression of carotid intima medial thickness.(26,27) This study did have certain limitations.”
MethodIt Takes a Village: Helping Families Live With Diabetes
Butler, D. A., & Lawlor, M. T. (2004) · Diabetes Spectrum · doi:10.2337/diaspect.17.1.26 · Cited by 13
de Andrade, C. R. M., Silva, E. L. C., da Matta, M. D. F. B., Castier, M. B., Rosa, M. L. G., & Gomes, M. B. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0891-8 · Cited by 11
Hishikawa, A., Hayashi, K., Kubo, A., Miyashita, K., Hashiguchi, A., Kinouchi, K., Yoshimoto, N., Nakamichi, R., Akashio, R., Sugita, E., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103436 · Cited by 12
“…treatments or insults on disease progression and complications for longer periods, has been recognized in large clinical trials of diabetes (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group et al., 2000; Nathan et al., 2003, 2005).”
BackgroundJiang, Y., Li, Y., Ding, Y., Ma, X., Ma, X., Bao, L., Zhang, Z., & Li, Y. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.991679 · Cited by 12
Bégorre, M.-A., Dib, A., Habchi, K., Guihot, A., Bourreau, J., Vessières, E., Blondeau, B., Loufrani, L., Chabbert, M., Henrion, D., et al. (2017) · Scientific Reports · doi:10.1038/srep45625 · Cited by 12
Miyabe, M., Kurajoh, M., Mori, K., Okuno, S., Okada, S., Emoto, M., Tsujimoto, Y., & Inaba, M. (2019) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563219873688 · Cited by 12
Shi, M., Tang, R., Huang, F., Zhong, T., Chen, Y., Li, X., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3423 · Cited by 13
Zhang, L., Jiang, X., Liu, N., Li, M., Kang, J., Chen, L., Tang, J., Dong, S., Lu, F., & Zhang, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16688 · Cited by 12
Macrovascular disease in diabetes
Fisher, M. (2006) · Medicine · doi:10.1383/medc.2006.34.3.101 · Cited by 12
Disfunção endotelial no diabetes melito tipo 1
Bertoluci, M. C., Cé, G. V., da Silva, A. M. V., & Puñales, M. K. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200030 · Cited by 13
Gottsäter, A., Szelag, B., Berglund, G. L., Wroblewski, M., & Sundkvist, G. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.02.001 · Cited by 12
Molecular Intricacies and the Role of ER Stress in Diabetes
Balasubramanyam, M., Singh, L. P., & Rangasamy, S. (2012) · Experimental Diabetes Research · doi:10.1155/2012/958169 · Cited by 14
Ghazaiean, M., Najafi, B., Zamanfar, D., & Alipour, M. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-57205-9 · Cited by 14
Borderie, G., Foussard, N., Larroumet, A., Blanco, L., Barbet‐Massin, M., Ducos, C., Arab, L. R., Domenge, F., Mohammedi, K., Ducasse, É., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108595 · Cited by 11
The effects of metformin on maternal haemodynamics in gestational diabetes mellitus: A pilot study
Osman, M. W., Nath, M., Khalil, A. A., Webb, D. R., Robinson, T. G., & Mousa, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.003 · Cited by 11
Lack of evidence for progression of atherosclerosis during puberty in type 1 diabetes
Peña, A. S., Maftei, O., Harrington, J., Anderson, J. J. A., Hirte, C., Gent, R. J., & Couper, J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12265 · Cited by 11
“during DCCT was associated with a slower progression of cIMT in the first 6 yr post-DCCT (12), but this”
BackgroundA Study of Evaluation for the Management of Diabetes in Bangladesh
Sultana, Z., Ali, M. E., Akhtar, M. A., Uddin, M. S., & Haque, M. M. (2013) · Pharmacology & Pharmacy · doi:10.4236/pp.2013.43051 · Cited by 11
“The importance of tight glycemic control in preventing chronic complications has been previously underscored by a number of studies [26-30].”
BackgroundAlpha Lipoic Acid Treatment Improved Endothelium-dependent Relaxation in Diabetic Rat Aorta
Okudan, N., Atalık, K. E. N., Gökbel, H., Canbilen, A. E., & Kara, İ. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.739 · Cited by 11
Blood Glucose and Cerebrovascular Disease in Nondiabetic Patients
Nielson, C., & Fleming, R. M. (2007) · Angiology · doi:10.1177/0003319707303695 · Cited by 11
The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes
Subramanian, S. L., & Hirsch, I. B. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0010 · Cited by 11
Zoungas, S., Kerr, P. G., Lui, M. L., & Teede, H. J. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00901.x · Cited by 11
Metadata
- Authors
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
- Corresponding author
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-06-05
- Volume
- 348
- Issue
- 23
- Pages
- 2294-2303
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2701300
- OpenAlex
- W1667957779
- Cited by
- 815
- References
- 46
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 13 · 2022: 7 · 2021: 22 · 2020: 20 · 2019: 26 · 2018: 21 · 2017: 24 · 2016: 21 · 2015: 41 · 2014: 34 · 2013: 37 · 2012: 41
- FWCI
- 39.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- National Institutes of Health (n01dk062204-003)
- Genentech
- National Institute of Diabetes and Digestive and Kidney Diseases (N01 DK062204)
- National Center for Research Resources
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- type 1 diabetes, intensive diabetes therapy, carotid intima-media thickness, atherosclerosis, cardiovascular risk, glycemic control, HbA1c, Diabetes Control and Complications Trial, carotid artery, LDL/HDL ratio, urinary albumin excretion, smoking, systolic blood pressure
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Arteriosclerosis, Blood Glucose, Carotid Artery Diseases, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Humans, Lipids, Male, Risk Factors, Ultrasonography, Linear Models, Least-Squares Analysis, Case-Control Studies, Randomized Controlled Trials as Topic, Carotid Artery, Common, Tunica Intima, Tunica Media, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
